Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MMED · against 227 other Healthcare companies of similar size
Ranked #136 of 228 · scores higher than 41% of peers
Bars: peers in each 10-point band of the valuation score29 peers with a valuation score of 40–49, including MMED · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | MMED | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 226 reported | -5.9% | 2.4% | 13% | 30% | |
| EBITDA yieldHigher is better · 225 reported | 5.4% | 4.5% | 56% | 50% | |
| Free cash flow yieldHigher is better · 127 reported | -6.0% | 0.8% | 11% | 20% | |
| Book yieldHigher is better · 227 reported | 68.3% | 25.2% | 87% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 4 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 4 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 130 | 249.2B INR (≈$3.0B) | 48 | 73 | |
| 133 | 7.0B USD | 47 | 63 | |
| 133 | 596.9B INR (≈$7.2B) | 47 | 58 | |
| 135 | 5.76T KRW (≈$4.1B) | 46 | 59 | |
| 136 | 5.3B USD | 45 | 50 | |
| 137 | 21.6B CNY (≈$3.0B) | 44 | 41 | |
| 137 | 10.5B USD | 44 | 56 | |
| 137 | 321.5B INR (≈$3.9B) | 44 | 70 | |
| 137 | 871.6B INR (≈$10.5B) | 44 | 66 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score